Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study

Medicina (Kaunas). 2023 Dec 18;59(12):2196. doi: 10.3390/medicina59122196.

Abstract

Background and Objectives: Pain management poses a significant challenge for patients experiencing vaso-occlusive crisis (VOC) in sickle cell disease (SCD). While opioid therapy is highly effective, its efficacy can be impeded by undesirable side effects. Local regional anesthesia (LRA), involving the deposition of a perineural anesthetic, provides a nociceptive blockade, local vasodilation and reduces the inflammatory response. However, the effectiveness of this therapeutic approach for VOC in SCD patients has been rarely reported up to now. The objective of this study was to assess the effectiveness of a single-shot local regional anesthesia (LRA) in reducing pain and consequently enhancing the management of severe vaso-occlusive crisis (VOC) in adults with sickle cell disease (SCD) unresponsive to conventional analgesic therapy. Materials and Methods: We first collected consecutive episodes of VOC in critical care (ICU and emergency room) for six months in 2022 in a French University hospital with a large population of sickle cell patients in the West Indies population. We also performed a systematic review of the use of LRA in SCD. The primary outcome was defined using a numeric pain score (NPS) and/or percentage of change in opioid use. Results: We enrolled nine SCD adults (28 years old, 4 females) for ten episodes of VOC in whom LRA was used for pain management. Opioid reduction within the first 24 h post block was -75% (50 to 96%). Similarly, the NPS decreased from 9/10 pre-block to 0-1/10 post-block. Five studies, including one case series with three patients and four case reports, employed peripheral nerve blocks for regional anesthesia. In general, local regional anesthesia (LRA) exhibited a reduction in pain and symptoms, along with a decrease in opioid consumption post-procedure. Conclusions: LRA improves pain scores, reduces opioid consumption in SCD patients with refractory pain, and may mitigate opioid-related side effects while facilitating the transition to oral analgesics. Furthermore, LRA is a safe and effective procedure.

Keywords: acute pain and peri-operative medicine; anatomic and techniques; chronic pain; emergency pain; sickle cell disease; vaso-occlusive crisis.

Publication types

  • Systematic Review

MeSH terms

  • Adult
  • Analgesics / therapeutic use
  • Analgesics, Opioid / therapeutic use
  • Anemia, Sickle Cell* / complications
  • Female
  • Humans
  • Pain / drug therapy
  • Pain / etiology
  • Pain Management / methods
  • Retrospective Studies
  • Volatile Organic Compounds*

Substances

  • Analgesics, Opioid
  • Volatile Organic Compounds
  • Analgesics

Grants and funding

This research was funded by the University Hospital of La Guadeloupe (APL 2020 funding: 13,658 €).